Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that focuses on fostering the development and adoption of new technologies in the region. For over 30 years, it has served as a key provider of seed-stage capital, investing more than $170 million in over 1,750 regional technology companies, many of which have achieved industry leadership. In addition to financial support, Ben Franklin promotes university and industry partnerships that facilitate the commercialization of scientific discoveries. The organization is dedicated to strengthening the entrepreneurial ecosystem in Southeastern Pennsylvania, thereby creating jobs and enhancing the technology community.

Focus

Therapeutics Pharmaceuticals Wireless Health Diagnostics Biotechnology Show more

http://www.sep.benfranklin.org

https://crunchbase.com/organization/ben-franklin-technology-partners-of-southeastern-pennsylvania

https://facebook.com/bftp.sep

https://linkedin.com/company/534321

https://signal.nfx.com/firms/ben-franklin-technology-partners-of-southeastern-pennsylvania

https://twitter.com/bftp_sep

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=19149

https://www.privateequityinternational.com/database/#/profile?id=15552

Jason Bannon

Vice President of Marketing and Communications

Jonathon Beschen

Managing Director

Patrick J. Foley

Former Member of Physical Sciences Investment Advisory Committee

Elaine Fulton

Receptionist & Operations Assistant

Richard E. Genzer

Investor

Mark de Grandpre

Investor

Jennifer Hartt

Managing Director

John A. Loftus

Director

Tristan Ly

Director of Portfolio Administration

Adare Mcmillan

Chief Administrative Officer and Assistant Treasurer

OMAR G. MENCIN, DBA

Managing Director

Douglas R. Petillo

Member of Information Technology Investment Advisory Committee

Aston Pierce

Investor

Charles M. Robins

Director

Stephen Spinelli

Director

Kate Srinivasan

Client Engagement Manager

Mark S. Trabbold

Director of Business Development

Past deals in Laser

Photosonix Medical

Seed Round in 2014

Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists and primary care physicians. Photosonix Medical is based in Ambler, Pennsylvania.